Citation Impact
Citing Papers
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
2010
Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
2007
Computational Radiomics System to Decode the Radiographic Phenotype
2017 Standout
Molecular imaging of hypoxia with radiolabelled agents
2009
Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy
2007
Gastric cancer
2016 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer – Comparison of dose, toxicity and cost-effectiveness
2016
Radiation‐induced xerostomia in patients with head and neck cancer
2006
Discordant Response to Chemotherapy Detected by PET Scanning
2002
Rapid learning in practice: A lung cancer survival decision support system in routine patient care data
2014
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Monitoring chemotherapy and radiotherapy of solid tumors
2006
Efficacy of Preoperative Combined 18-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography for Assessing Primary Rectal Cancer Response to Neoadjuvant Therapy
2007
Metabolic Tumor Width Parameters as Determined on PET/CT Predict Disease-free Survival and Treatment Response in Squamous Cell Carcinoma of the Esophagus
2008
Predictive Value of 18-Fluoro-Deoxy-Glucose-Positron Emission Tomography (18F-FDG-PET) in the Identification of Responders to Chemoradiation Therapy for the Treatment of Locally Advanced Esophageal Cancer
2006
Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type
1999
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
2005
Imaging in the era of molecular oncology
2008 StandoutNature
2-Deoxy-2[F-18]FDG-PET for Detection of Recurrent Laryngeal Carcinoma after Radiotherapy: Interobserver Variability in Reporting
2008
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1
2004
Lung Cancer
2008 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET Scans
2007
Head and neck cancer
2008 Standout
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma
2001
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Nasopharyngeal carcinoma
2019 Standout
Esophageal Cancer
2003 Standout
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
2011
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data
2001
Strategies for in vivo imaging of enzyme activity: an overview and recent advances
2011
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Radioembolization for hepatocellular carcinoma
2011
Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
2011
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
2010
Oesophageal carcinoma
2013 Standout
DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
2009
A prospective evaluation of the utility of 2‐deoxy‐2‐[18F]fluoro‐D ‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer
2012
Immunotherapy and chemotherapy — a practical partnership
2005
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging
2011
Dendritic Cell Therapy of High‐Grade Gliomas
2009
Hematopoietic Stem-Cell Transplantation
2006 Standout
The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments
2007
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Pitfalls in the diagnosis of brain tumours
2006
Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
2010
Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer
2008
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
2‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma
2004
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer
2006
Interactions with Aromatic Rings in Chemical and Biological Recognition
2003 Standout
Gastric cancer
2020 Standout
Primary brain tumours in adults
2012 Standout
Immunotherapy for the Treatment of Glioblastoma
2012
[18F]Fluorodeoxyglucose Uptake in Recurrent Thyroid Cancer Is Related to Hexokinase I Expression in the Primary Tumor
2005
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer
2006
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Unmet needs and challenges in gastric cancer: The way forward
2014
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate‐pulsed dendritic cells in a murine glioma model
2007
International data-sharing for radiotherapy research: An open-source based infrastructure for multicentric clinical data mining
2013
DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMAS
2006
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The Pathobiology of Vascular Dementia
2013 Standout
‘Rapid Learning health care in oncology’ – An approach towards decision support systems enabling customised radiotherapy’
2013
Utility of PET, CT, and EUS to Identify Pathologic Responders in Esophageal Cancer
2004
Artificial intelligence in radiology
2018 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
2016 StandoutNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis
2014
Controversies in the Management of Oropharynx Cancer
2008
Methods for Noninvasive Imaging of Tissue Hypoxia
2007
Sulfatase-activated fluorophores for rapid discrimination of mycobacterial species and strains
2013 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Branhamella catarrhalis: an organism gaining respect as a pathogen
1990 Standout
Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer
2005
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas
2006
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Head and Neck Cancer
2020 Standout
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
2003
Use of PET for monitoring cancer therapy and for predicting outcome.
2005
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
2019
18F-FDG PET detection of colonic adenomas.
2001
When, in the context of drug design, can a fluorine atom successfully substitute a hydroxyl group?
2002
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
2008
Sigma Receptors and Cancer
2004
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
B.CAT CONFIRM, a rapid test for confirmation of Branhamella catarrhalis
1989
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Identification of Branhamella catarrhalis in 2.5 min with an indoxyl butyrate strip test
1989
Positron-Emission Tomography and Assessment of Cancer Therapy
2006
Increased Metabolic Activity on 18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Human Immunodeficiency Virus–Associated Immune Reconstitution Inflammatory Syndrome
2018
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Evaluation of 18F‐2‐deoxy‐2‐fluoro‐d ‐glucose Positron Emission Tomography for Gastric Cancer
2004
Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial
2003
Selective medium for Branhamella catarrhalis with acetazolamide as a specific inhibitor of Neisseria spp
1988
PET-based treatment planning in radiotherapy: a new standard?
2007
Cancer Genome Landscapes
2013 StandoutScience
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
18F-FDG PET/CT Imaging In Oncology
2011
Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment
2005
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study
2008
Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
2005
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
2001
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients
2008
Works of Patrick Flamen being referenced
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
2004
18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer
2005
Histopathologic Validation of Lymph Node Staging With FDG-PET Scan in Cancer of the Esophagus and Gastroesophageal Junction
2000
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy
2004
Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer
2004
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy
2001
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
2008
Evaluation of hypoxia in an experimental rat tumour model by [18F]Fluoromisonidazole PET and immunohistochemistry
2004
Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
2002
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?
2004
Progressive Osteoblastic Bone Metastases in Breast Cancer Negative on FDG-PET
2009
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
2000
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer
2002
Imaging of renal cell cancer with radiolabeled octreotide
1993
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres
2008
Paget bone disease demonstrated on 68Ga-PSMA ligand PET/CT
2015
Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer
2001
Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value
2004
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy
2012
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: Exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer
2010
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipies.
2006
Clinical impact of 68 Ga‐prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate‐specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
2016
A new imaging technique for colorectal cancer: positron emission tomography.
2000
SoMore trial: Early metabolic response assessment of a sorafenib (SOR) and capecitabine (CAP) combination in chemorefractory metastatic colorectal cancer (mCRC).
2014
Preservation of parotid function with uncomplicated conformal radiotherapy
2002
Rapid identification of Branhamella catarrhalis with 4-methylumbelliferyl butyrate
1988
Role and interpretation of fluorodeoxyglucose‐positron emission tomography/computed tomography in HIV ‐infected patients with fever of unknown origin: a prospective study
2013
Additional Value of Whole-Body Positron Emission Tomography With Fluorine-18-2-Fluoro-2-deoxy-d -glucose in Recurrent Colorectal Cancer
1999
Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
2000
Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
1997
18FDG PET in oncology: The best and the worst (Review)
2006